Tolerability of lumiracoxib in patients with analgesic intolerance.
Celikel
S
S
Hacettepe University School ofMedicine, Department of Chest Diseases, Adult Allergy Unit Ankara, Turkey. scelikel@gmail.com
Isik
S R
SR
Karakaya
G
G
Kalyoncu
A F
AF
D000284:Administration, Oral; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004008:Diclofenac / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008875:Middle Aged
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D004008:Diclofenac; C473384:lumiracoxib